Cargando…
Identification of several high-risk HPV inhibitors and drug targets with a novel high-throughput screening assay
Human papillomaviruses (HPVs) are oncogenic viruses that cause numerous different cancers as well as benign lesions in the epithelia. To date, there is no effective cure for an ongoing HPV infection. Here, we describe the generation process of a platform for the development of anti-HPV drugs. This s...
Autores principales: | Toots, Mart, Ustav, Mart, Männik, Andres, Mumm, Karl, Tämm, Kaido, Tamm, Tarmo, Ustav, Ene |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5300127/ https://www.ncbi.nlm.nih.gov/pubmed/28182794 http://dx.doi.org/10.1371/journal.ppat.1006168 |
Ejemplares similares
-
The Transcription Map of Human Papillomavirus Type 18 during Genome Replication in U2OS Cells
por: Toots, Mart, et al.
Publicado: (2014) -
The transcription map of HPV11 in U2OS cells adequately reflects the initial and stable replication phases of the viral genome
por: Isok-Paas, Helen, et al.
Publicado: (2015) -
The Cell Cycle Timing of Human Papillomavirus DNA Replication
por: Reinson, Tormi, et al.
Publicado: (2015) -
The molecular biology and HPV drug responsiveness of cynomolgus macaque papillomaviruses support their use in the development of a relevant in vivo model for antiviral drug testing
por: Tombak, Eva-Maria, et al.
Publicado: (2019) -
Human Papillomavirus Type 18 cis-Elements Crucial for Segregation and Latency
por: Ustav, Mart, et al.
Publicado: (2015)